| Literature DB >> 8683220 |
T Kaneko1, I Nakamura, H Kita, K Hiroishi, T Moriyama, M Imawari.
Abstract
Cytotoxic T lymphocytes (CTLs) may play a role in host defence against hepatitis C virus (HCV) infection, and HCV-specific CTL epitopes may be included in vaccines to induce protective CTLs. We identified three new epitopes within the HCV nucleoprotein recognized by CTLs. HCV nucleoprotein residues 28-37 are the minimal epitope recognized by CTLs in association with the class I human leukocyte antigen B60, and epitopes in HCV nucleoprotein residues 111-130 and 161-180 are both recognized by CTLs in association with the class II human leukocyte antigen DRBI*08032.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8683220 DOI: 10.1099/0022-1317-77-6-1305
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891